Prognostic Significance of (18)F-FDG PET/CT and Tumor Metabolic Changes in Patients With Pancreatic Ductal Adenocarcinoma. Shimomura A, Oshima M, Suto H, Matsukawa H, et al. Anticancer Res 2024;44:3321-3330.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shimomura A, Oshima M, Suto H, Matsukawa H, et al. Prognostic Significance of (18)F-FDG PET/CT and Tumor Metabolic Changes in Patients With Pancreatic Ductal Adenocarcinoma. Anticancer Res 2024;44:3321-3330.
PMID: 39060044